Crinetics Pharmaceuticals (CRNX) EBT Margin Growth (1y) (2018 - 2026)
Crinetics Pharmaceuticals (CRNX) EBT Margin Growth (1y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,222.41 Bn | 67,222.13 Bn | - | - |
| 2 | Nanobiotix | 1,909.44 Bn | 1,909.38 Bn | - | - |
| 3 | Akari Therapeutics | 989.71 Bn | 989.71 Bn | - | - |
| 4 | BeOne Medicines | 471.12 Bn | 466.33 Bn | 1.35 Bn | 1,526.00 |
| 5 | Vertex Pharmaceuticals | 121.84 Bn | 114.59 Bn | 2.59 Bn | 1,558.00 |
| 6 | Regeneron Pharmaceuticals | 69.89 Bn | 61.14 Bn | 3.31 Bn | -683.00 |
| 7 | Belite Bio | 62.74 Bn | 62.74 Bn | - | - |
| 8 | Argenx Se | 55.83 Bn | 50.64 Bn | 1.41 Bn | 452.00 |
| 9 | Alnylam Pharmaceuticals | 37.34 Bn | 34.34 Bn | 959.66 Mn | 1,939.00 |
| 10 | Crinetics Pharmaceuticals | 8.74 Bn | 7.44 Bn | 10.53 Mn | -2.91 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.91 Mn |
| Jun 30, 2025 | -734,415.00 |
| Mar 31, 2025 | 1.64 Mn |
| Jun 30, 2024 | 1.34 Mn |
| Mar 31, 2024 | 866,750.00 |
| Sep 30, 2023 | 716,428.00 |
| Jun 30, 2023 | -449,280.00 |
| Mar 31, 2023 | 64,319.00 |
| Dec 31, 2022 | 2.35 Mn |
| Dec 31, 2021 | -4.82 Mn |
| Dec 31, 2020 | 3.57 Mn |
| Mar 31, 2020 | -3.82 Mn |
| Dec 31, 2019 | -193,896.00 |
| Sep 30, 2019 | 400,906.00 |
| Mar 31, 2019 | -1.19 Mn |
| Dec 31, 2018 | -220,819.00 |
| Sep 30, 2018 | -1.05 Mn |
| Jun 30, 2018 | -296,267.00 |